Literature DB >> 21865262

Differential interaction of dicarboxylates with human sodium-dicarboxylate cotransporter 3 and organic anion transporters 1 and 3.

Marcel Kaufhold1, Katharina Schulz, Davorka Breljak, Shivangi Gupta, Maja Henjakovic, Wolfgang Krick, Yohannes Hagos, Ivan Sabolic, Birgitta C Burckhardt, Gerhard Burckhardt.   

Abstract

Organic anions are taken up from the blood into proximal tubule cells by organic anion transporters 1 and 3 (OAT1 and OAT3) in exchange for dicarboxylates. The released dicarboxylates are recycled by the sodium dicarboxylate cotransporter 3 (NaDC3). In this study, we tested the substrate specificities of human NaDC3, OAT1, and OAT3 to identify those dicarboxylates for which the three cooperating transporters have common high affinities. All transporters were stably expressed in HEK293 cells, and extracellularly added dicarboxylates were used as inhibitors of [(14)C]succinate (NaDC3), p-[(3)H]aminohippurate (OAT1), or [(3)H]estrone-3-sulfate (OAT3) uptake. Human NaDC3 was stably expressed as proven by immunochemical methods and by sodium-dependent uptake of succinate (K(0.5) for sodium activation, 44.6 mM; Hill coefficient, 2.1; K(m) for succinate, 18 μM). NaDC3 was best inhibited by succinate (IC(50) 25.5 μM) and less by α-ketoglutarate (IC(50) 69.2 μM) and fumarate (IC(50) 95.2 μM). Dicarboxylates with longer carbon backbones (adipate, pimelate, suberate) had low or no affinity for NaDC3. OAT1 exhibited the highest affinity for glutarate, α-ketoglutarate, and adipate (IC(50) between 3.3 and 6.2 μM), followed by pimelate (18.6 μM) and suberate (19.3 μM). The affinity of OAT1 to succinate and fumarate was low. OAT3 showed the same dicarboxylate selectivity with ∼13-fold higher IC(50) values compared with OAT1. The data 1) reveal α-ketoglutarate as a common high-affinity substrate of NaDC3, OAT1, and OAT3 and 2) suggest potentially similar molecular structures of the binding sites in OAT1 and OAT3 for dicarboxylates.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21865262     DOI: 10.1152/ajprenal.00169.2011

Source DB:  PubMed          Journal:  Am J Physiol Renal Physiol        ISSN: 1522-1466


  14 in total

1.  Tumor microenvironment promotes dicarboxylic acid carrier-mediated transport of succinate to fuel prostate cancer mitochondria.

Authors:  Aigul Zhunussova; Bhaswati Sen; Leah Friedman; Sultan Tuleukhanov; Ari D Brooks; Richard Sensenig; Zulfiya Orynbayeva
Journal:  Am J Cancer Res       Date:  2015-04-15       Impact factor: 6.166

2.  α-Ketoglutarate-related inhibitors of HIF prolyl hydroxylases are substrates of renal organic anion transporters 1 (OAT1) and 4 (OAT4).

Authors:  Yohannes Hagos; Gunnar Schley; Johannes Schödel; Wolfgang Krick; Gerhard Burckhardt; Carsten Willam; Birgitta C Burckhardt
Journal:  Pflugers Arch       Date:  2012-08-09       Impact factor: 3.657

Review 3.  Sodium-coupled dicarboxylate and citrate transporters from the SLC13 family.

Authors:  Ana M Pajor
Journal:  Pflugers Arch       Date:  2013-10-10       Impact factor: 3.657

4.  Counter-flow suggests transport of dantrolene and 5-OH dantrolene by the organic anion transporters 2 (OAT2) and 3 (OAT3).

Authors:  Birgitta C Burckhardt; Maja Henjakovic; Yohannes Hagos; Gerhard Burckhardt
Journal:  Pflugers Arch       Date:  2016-11-03       Impact factor: 3.657

5.  Diagnostic value of plasma and urinary 2-hydroxyglutarate to identify patients with isocitrate dehydrogenase-mutated glioma.

Authors:  Giuseppe Lombardi; Giuseppe Corona; Luisa Bellu; Alessandro Della Puppa; Ardi Pambuku; Pasquale Fiduccia; Roberta Bertorelle; Marina Paola Gardiman; Domenico D'Avella; Giuseppe Toffoli; Vittorina Zagonel
Journal:  Oncologist       Date:  2015-04-10

6.  Determinants of substrate and cation transport in the human Na+/dicarboxylate cotransporter NaDC3.

Authors:  Avner Schlessinger; Nina N Sun; Claire Colas; Ana M Pajor
Journal:  J Biol Chem       Date:  2014-05-07       Impact factor: 5.157

7.  Mutations in the Na(+)/citrate cotransporter NaCT (SLC13A5) in pediatric patients with epilepsy and developmental delay.

Authors:  Jenna Klotz; Brenda E Porter; Claire Colas; Avner Schlessinger; Ana M Pajor
Journal:  Mol Med       Date:  2016-05-26       Impact factor: 6.354

Review 8.  Renal transport of uric acid: evolving concepts and uncertainties.

Authors:  Ion Alexandru Bobulescu; Orson W Moe
Journal:  Adv Chronic Kidney Dis       Date:  2012-11       Impact factor: 3.620

9.  C9orf72 expansion within astrocytes reduces metabolic flexibility in amyotrophic lateral sclerosis.

Authors:  Scott P Allen; Benjamin Hall; Ryan Woof; Laura Francis; Noemi Gatto; Allan C Shaw; Monika Myszczynska; Jordan Hemingway; Ian Coldicott; Amelia Willcock; Lucy Job; Rachel M Hughes; Camilla Boschian; Nadhim Bayatti; Paul R Heath; Oliver Bandmann; Heather Mortiboys; Laura Ferraiuolo; Pamela J Shaw
Journal:  Brain       Date:  2019-12-01       Impact factor: 13.501

10.  Integrated compensatory network is activated in the absence of NCC phosphorylation.

Authors:  P Richard Grimm; Yoskaly Lazo-Fernandez; Eric Delpire; Susan M Wall; Susan G Dorsey; Edward J Weinman; Richard Coleman; James B Wade; Paul A Welling
Journal:  J Clin Invest       Date:  2015-04-20       Impact factor: 14.808

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.